Agios
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agios and other ETFs, options, and stocks.About AGIO
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology.
AGIO Key Statistics
Stock Snapshot
As of today, Agios(AGIO) shares are valued at $29.14. The company's market cap stands at 1.75B, with a P/E ratio of -4.05.
As of 2026-05-30, Agios(AGIO) stock has fluctuated between $26.22 and $30.28. The current price stands at $29.14, placing the stock +11.1% above today's low and -3.8% off the high.
Agios(AGIO) shares are trading with a volume of 1.43M, against a daily average of 833.61K.
During the past year, Agios(AGIO) stock moved between $22.24 at its lowest and $46.00 at its peak.
During the past year, Agios(AGIO) stock moved between $22.24 at its lowest and $46.00 at its peak.
AGIO News
Agios Pharmaceuticals (AGIO) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analy...
BofA lowered the firm’s price target on Agios Pharmaceuticals (AGIO) to $40 from $41 and keeps a Buy rating on the shares after the company announced tebapivat...
Earlier in May 2026, the European Commission granted marketing authorization for Agios Pharmaceuticals’ PYRUKYND (mitapivat) to treat anemia in adults with tran...
Analyst ratings
70%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.